• Home
  • Randomize
  • Aim and mission
  • News
  • Newsletters
  • Contact
  • Organization (investigators, collaborators and funders)
  • Data requests
    • Publication policy CONTRAST
    • DATA REQUEST FORM (internal parties)
    • DATA REQUEST FORM (external parties)
  • Work packages info
    • WP1: Improving microvascular reperfusion
    • WP2: MR ASAP
    • WP3A: MR CLEAN LATE
    • WP3B: MR CLEAN MED
    • WP3C: MR CLEAN NO-IV
    • WP4: Dutch ICH pilot
    • WP5: Biobank
    • WP6: Clinical data management
    • WP7: Imaging data management
    • WP8: Logistics and epidemiology
    • WPYT: Young talent program
  • Investigators
    • Randomize for MR CLEAN NO-IV
    • Randomize for MR CLEAN-LATE
    • Randomize for MR CLEAN-MED
    • Include for Dutch ICH pilot
    • Access to Open Clinica
    • Access to XNAT
    • Newsletter
    • CONTRAST PLAZA
  • Documents
  • Ongoing Trials
    • CASES
      • Randomization
      • Rationale and aim
      • Study design
      • Trial organization (investigators, collaborators and funders)
      • Trial protocol and trial documents
      • Trial progress
      • NEWS
      • Contact
      • Ontslaggegevens/discharge data
      • Links
      • FAQ
  • Closed trials
  • Links


MR CLEAN-NOIV

WP Leaders: Charles Majoie (Amsterdam UMC) and Yvo Roos (Amsterdam UMC)

Aim: To assess the effect of direct endovascular treatment compared with intravenous thrombolytic treatment followed by EVT (when indicated), in patients with acute ischemic stroke, caused by CTA confirmed anterior circulation occlusion.

Click here for the MR CLEAN-NOIV website